clinical trial · NCT07543419
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
Hidradenitis Suppurativa
brief summary
The aim of this study is to generate real-world evidence to fill knowledge gaps regarding the response to secukinumab in patients with moderate to severe HS, its treatment patterns, the clinical characteristics of patients on secukinumab, healthcare resource utilization and the economic impact of HS in Italy.
started
Dec 17, 2025
primary completion
Sep 30, 2028
completion
Sep 30, 2028
last updated
Apr 21, 2026
official title
Long Term Observational, Prospective, Multicenter Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) Within the Italian Population (ANIMA - Italy)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol